Our Team
Meet the people behind Variant Bio
Our team's expertise spans genetics, molecular biology, therapeutics, anthropology, and ethics. We are united in the belief that human genomics has the power to transform drug development.
Andrew Farnum
Chief Executive Officer
Craig Basson, MD, PhD
Chief Medical Officer, President of R&D
Holly Vance
Chief Operating Officer
Stephane Castel, PhD
Co-Founder, Chief Scientific & Technology Officer
Bob Kang
Business Development
Kairi Beck
Finance & Accounting
Laura Yerges-Armstrong, PhD
Computational Genetics
Leslie Hepner
Operations
Melissa Hendershott, PhD
Genomic Partnership Implementation
Prathap Kasina
Genomic Partnerships & Business Development
Rob Flickenger
Research Infrastructure
Sarah LeBaron von Baeyer, PhD
Ethics & Engagement
Sharon Crugnale
Development Operations
Swapan Chowdhury, PhD
Clinical Pharmacology & Nonclinical Sciences
Todd Meyer, PhD
Medicinal Chemistry
Yvette Latchman, PhD
Discovery Research
Our Investors
